Divergent Survival Outcomes With Adjuvant Chemotherapy in Stage IA Ovarian Clear Cell Carcinoma: Insights From the SEER Database
Adjuvant chemotherapy did not significantly improve survival outcomes in patients with Stage IA OCCC. However, its effects were age-dependent, with older patients (> 70 years) experiencing improved survival, while younger patients (≤ 50 years) exhibited worse outcomes. These findings underscore the importance of individualized treatment strategies for Stage IA OCCC.
Authors
- Xiang Yuan (ORCID: https://orcid.org/0009-0005-0012-4630)
- Xia Wang (ORCID: https://orcid.org/0000-0002-6986-0979)
- Wei Liu (ORCID: https://orcid.org/0009-0005-1767-5295)
- Jing Guo (ORCID: https://orcid.org/0000-0002-1133-3260)
- Luping Pan
Institutions
- Shangrao Normal University (CN)
- Nanchang University (CN)
- Jiangxi Provincial Cancer Hospital (CN)
- Second Affiliated Hospital of Nanchang University (CN)
- Community Health Center (US)
Publication Details
- Journal
- Obstetrics and Gynecology International
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1155/ogi/9983293
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00